Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

European Trial of Immunosuppression in SPK Tx

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by EUROSPK Study Group.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Fujisawa GmbH
Hoffmann-La Roche
Wyeth is now a wholly owned subsidiary of Pfizer
Neovii Biotech
Genzyme, a Sanofi Company
Information provided by:
EUROSPK Study Group
ClinicalTrials.gov Identifier:
NCT00140543
First received: August 31, 2005
Last updated: November 17, 2005
Last verified: August 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2008
  Estimated Primary Completion Date: No date given